Stocks
Denali Therapeutics (DNLI) ROE US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | -50.0% | 6.18% | -30.2% | -31.3% | -14.1% | -32.4% | ||
| Changes by years, y/y, % | -43pp | +56pp | -36pp | -1pp | +17pp | +16.3% | |||
Denali Therapeutics. ROE, %
Denali Therapeutics. ROE, changes, pp
Denali Therapeutics (DNLI) ROE US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| ROE, % | ? | -11.1% | -14.1% | -9.43% | -30.3% | -32.4% | -32.4% | |
| Changes by years, y/y, % | +26pp | +17pp | +29pp | -19pp | -21pp | |||
| Changes by quarters, q/q, % | 0pp | -3pp | +5pp | -21pp | -2pp | |||
